INBS - יחס חוב להיוון בספרים ibs.inc

Intelligent Bio Solutions is diversifying its fingerprint bioanalysis sales across forensics and sports. The total debt-to-capitalization ratio on GURU.Markets illustrates the financial stability trend, where 0.35 reflects the latest value of the metric. The uniqueness of non-invasive tests allows the company to maintain premium pricing, while steady demand for medtech minimizes the impact of macroeconomic cycles.

This ratio determines the extent of the company's reliance on debt relative to its balance sheet equity. Investors utilize this metric to assess financial stability and the acceptable level of debt load. Correlating financial liabilities with book capitalization on the GURU.Markets platform allows users to filter out market noise and identify actual leverage. For Intelligent Bio Solutions (INBS), this balance is critical when scaling the Intelligent Fingerprinting system. An increase in borrowings is permissible only if B2B sales accelerate and regulatory approvals in the US are successfully obtained.